By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mediomics has reeled in $460,000 from the National Institute of General Medical Sciences through a Phase II Small Business Technology Transfer (STTR) grant.

The company plans to use the funds to develop and increase the sensitivity of its biosensor technology and to develop its PINCER protein assay. Mediomics is commercializing core technologies it has licensed under an exclusive agreement with Saint Louis University.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.